Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001242532.5(MFSD11):c.436A>G(p.Ser146Gly) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
MFSD11 (HGNC:25458): (major facilitator superfamily domain containing 11) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.436A>G (p.S146G) alteration is located in exon 5 (coding exon 5) of the MFSD11 gene. This alteration results from a A to G substitution at nucleotide position 436, causing the serine (S) at amino acid position 146 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Gain of glycosylation at S145 (P = 0.0345);Gain of glycosylation at S145 (P = 0.0345);Gain of glycosylation at S145 (P = 0.0345);Gain of glycosylation at S145 (P = 0.0345);Gain of glycosylation at S145 (P = 0.0345);